COVID-19 Research : Remdesivir Intermediates For Research Purpose
Date of publication：2020/3/23 16:12:09
The 2019 novel coronavirus (COVID-19) has spread rapidly since its recent identification in patients with severe pneumonia in Wuhan, China. The pandemic has spread to over 150 countries and territories. Vaccines and treatment options for COVID-19 are currently being investigated around the world. There’s some evidence that certain medications may have the potential to be effective with regard to preventing illness or treating the symptoms of COVID-19.
In this phase of growing threat, Huateng Pharma plays its parts by providing the necessary drug intermediates which might be used for the research purpose of coronavirus treatment. We are able to provide the production of remdesivir intermediates and API for research use with capacities varying from gram to kilograms. Learn more>>
Remdesivir, also known as GS-5734, is a novel antiviral drug in the class of nucleotide analogs developed by Gilead Sciences. In February 2020 Remdesivir was being studied for experimental treatment of the emergent COVID-19 (novel coronavirus) disease.